President, Chief Executive Officer and Chairman of the Board · Century Therapeutics, Inc. (IPSC)

Brent Pfeiffenberger

A named executive officer of Century Therapeutics in every fiscal year CompBrief holds from FY2023 to FY2025. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2025

$2,381,022

Salary $640,625Stock awards $1,869,609

FY2024: $2,193,281

1st of 4 named executive officers at Century Therapeutics by FY2025 total.

4 named officers on file for Century Therapeutics, FY2025

Brent Pfeiffenberger’s pay file — $29

  • 3 fiscal years of pay, line by line
  • 1 equity grant, each cited to its filing

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Century Therapeutics’s whole pay program stands against its peers

  • Century Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on IPSC→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 27, 2026 (DEF 14A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get Brent Pfeiffenberger’s full pay file as a PDF — free

More than this page: up to 10 years of Brent’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Brent Pfeiffenberger compensation by year

Century Therapeutics Summary Compensation Table · all 3 fiscal years held
In US dollars, as Century Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2023FY2024FY2025
Salary$49,716$625,000$640,625
Bonus$200,000$450,000—
Stock awards$2,339,779$92,614$1,869,609
Option awards$621,167$392,000$222,681
Non-equity incentive$24,349$360,938$317,109
Pension and deferred compensation$0$0—
All other$0$272,729$13,998
Total$3,235,011$2,193,281$2,381,022

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Century Therapeutics, Inc. DEF 14A filed April 27, 2026, accession 0001104659-26-049489, and prior-year filings.

How this page was built: the Century Therapeutics, Inc. filed document, accession 0001104659-26-049489. Every figure is read from that document and cited to the page and table it appears in. Filed April 27, 2026.

$3.2M
$2.2M
$2.4M
FY23
FY24
FY25
SalaryBonusNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2025 year-end
TypeUnvested unitsValue at year-endExercise price
RSU1,587,614$1,579,676—
RSU586,887$586,953—
RSU521,500$518,892—
RSU9,802$9,753—
Option31,056—$1.61
Option255,792—$1.61
Option58,811—$5.32
Option521,500—$0.60

Per the Outstanding Equity Awards at Fiscal Year-End table in Century Therapeutics, Inc.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

7 Form 4 lines since the FY2025 proxy (filed April 27, 2026)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2026-11-13Tax withholding—31,172$1.653,602,667
2026-09-11Tax withholding—13,850$1.943,633,839
2026-09-04Tax withholding—463$2.113,633,839
2026-08-14Tax withholding—31,172$1.923,634,302
2026-06-11Tax withholding—13,849$2.243,665,474
2026-06-05Tax withholding—463$2.133,679,323
2026-05-15Tax withholding—31,172$2.343,679,786

The 7 most recent of 7 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

Century Therapeutics’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Brent Pfeiffenberger · this pagePresident, Chief Executive Officer and Chairman of the Board$2,381,022
Chad CowanChief Scientific Officer$1,167,015
Adrienne FaridFormer Chief Development Officer$989,403
Gregory RussottiChief Technology and Manufacturing Officer and former Interim President and Chief Executive Officer$912,320

Board service

Century Therapeutics board · FY2023–FY2024

How this board is paid

Company policy: Century Therapeutics pays directors a $40,000 cash retainer. As stated in Century Therapeutics's FY2024 proxy.

The full Century Therapeutics compensation record

free company brief

This page is one person within Century Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Century Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Brent Pfeiffenberger's compensation dossier · One-time report. No refunds.